European Urology

European Urology

欧洲泌尿外科

  • 1区 中科院分区
  • Q1 JCR分区

期刊简介

《European Urology》是由Elsevier出版社于1975年创办的英文国际期刊(ISSN: 0302-2838,E-ISSN: 1421-993X),该期刊长期致力于泌尿学与肾脏学领域的创新研究,主要研究方向为医学-泌尿学与肾脏学。作为SCI、SCIE收录期刊(JCR分区 Q1,中科院 1区),本刊采用OA未开放获取模式(OA占比0.1452...%),以发表泌尿学与肾脏学领域等方向的原创性研究为核心(研究类文章占比77.01%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在87篇,确保学术质量与前沿性。成果覆盖Web of ScienceWeb of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

European Urology审稿周期约为一般,3-6周。该刊近年未被列入国际预警名单,年发文量约87篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCI、SCIE 期刊收录
  • 87 发文量

中科院分区

《新锐期刊分区表》(2026年3月发布)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

期刊分区表(2025年3月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

期刊分区表(2023年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

期刊分区表(2022年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

期刊分区表(2021年12月升级版)

Top期刊 综述期刊 大类学科 小类学科
医学
1区
UROLOGY & NEPHROLOGY 泌尿学与肾脏学
1区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q1 2 / 134

98.9

学科:UROLOGY & NEPHROLOGY SCIE Q1 3 / 134

98.13

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q1 3 / 133

98.1

学科:UROLOGY & NEPHROLOGY SCIE Q1 2 / 133

98.87

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:UROLOGY & NEPHROLOGY SCIE Q1 2 / 126

98.8

学科:UROLOGY & NEPHROLOGY SCIE Q1 2 / 126

98.81

CiteScore(2026年6月最新版)

CiteScore SJR SNIP CiteScore 排名
CiteScore:45.9 SJR:8.715 SNIP:9.059
学科类别 分区 排名 百分位
大类:Medicine 小类:Urology Q1 1 / 123

99%

期刊发文

  • RESECT: A Randomised Controlled Trial of Audit and Feedback in Non-muscle-invasive Bladder Cancer Surger

    Author: Gallagher, Kevin; MacLennan, Steven; Bhatt, Nikita; Clement, Keiran; Zimmermann, Eleanor; Khadhouri, Sinan; Kulkarni, Meghana; Gaba, Fortis; Anbarasan, Thineskrishna; Asif, Aqua; Light, Alexander; Ng, Alexander; Chan, Vinson Wai-Shun; Nathan, Arjun; Cooper, David; Aucott, Lorna; Sakthivel, Deerush; Akand, Murat; Piazza, Pietro; Marcq, Gautier; O'Brien, Tim; Nielsen, Matthew; Del Giudice, Francesco; Geisenhoff, Alexander; Hill, George; Fukuokaya, Wataru; Gutierrez Hidalgo, Beatriz; El-Hajj, Albert; Elgamal, Mostafa; Fanshawe, Jack; Wang, Betty; Lee, Taeweon; Manecksha, Rustom; McCann, Conor; Gomez Rivas, Juan; Arda, Ersan; Elhadi, Muhammed; Rossi, Sabrina; Yuen-Chun Teoh, Jeremy; Mariappan, Paramananthan; Kasivisvanathan, Veeru

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 4, pp. 355-365. DOI: 10.1016/j.eururo.2025.09.4174

  • Re: Ferriol Calvet, Raquel Blanco Martinez-Illescas, Ferran Muiños, et al. Sex and Smoking Bias in the Selection of Somatic Mutations in Human Bladder. Nature. In press. https://doi.org/10.1038/s41586-025-09521-

    Author: Lin, Chunhua; Li, Conghui; Lv, Wei

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 4, pp. e101-e101. DOI: 10.1016/j.eururo.2025.11.002

  • Re: Stephen J. Freedland, John P. Mulhall, Martin Gleave, et al. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol 2025;87:507-1

    Author: Meng, Xianghu; Hua, Yibo; Song, Rijin

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 4, pp. e93-e102. DOI: 10.1016/j.eururo.2025.07.035

  • Emmeli Palmstedt, Marianne Månsson, Jonas Hugosson, Rebecka Arnsrud Godtman. Active Surveillance for Screen-detected Low-and Intermediate-risk Prostate Cancer: Extended Follow-up up to 25 Years in the GÖTEBORG-1 Trial. Eur Urol. 2025;88:373-38

    Author: Wang, Ziheng; Li, Xuenan; Zhao, Xin; Yang, Yi

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 4, pp. e97-e97. DOI: 10.1016/j.eururo.2025.08.035

  • Reply to Awais Ayub, Numair Tariq, and Shahroz Baloch's Letter to the Editor re: Guohua Zeng, Kehua Jiang, Shusheng Liu, et al. Flexible Ureteroscopy with a Flexible and Navigable Suction Ureteral Access Sheath Versus Mini-Percutaneous Nephrolithotomy for Treatment of 2-3 cm Renal Stones: An International, Multicenter, Randomized, Noninferiority Trial. Eur Urol. 2026;89:45-5

    Author: Zeng, Guohua; Yuen, Steffi Kar Kei; Gauhar, Vineet; Zhu, Wei

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 3, pp. e69-e69. DOI: 10.1016/j.eururo.2025.09.4158

  • Lars Holmberg, Hans Garmo, Sven-Olov Andersson, et al. Time Dependence of Outcomes in the SPCG-4 Randomized Trial Comparing Radical Prostatectomy and Watchful Waiting in Early Prostate Cance

    Author: Wang, Yafei; Lu, Qianting; Zhao, Xin

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 3, pp. e74-e74. DOI: 10.1016/j.eururo.2025.08.034

  • Re Arvin K. George, Ranko Miocinovic, Amit R. Patel, et al. Irreversible Electroporation for Prostate Tissue Ablation in Patients with Intermediate-risk Prostate Cancer: Results from the PRESERVE Trial. Eur Urol. 202

    Author: Liu, Hongquan; Sun, Fengze; Wu, Jitao

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 3, pp. e67-e68. DOI: 10.1016/j.eururo.2025.08.029

  • W. Marston Linehan, Cathy Anne Pinto, Yanfang Liu, et al. Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Diseas

    Author: Liao, Chongzhou; Zhang, Ting; Lv, Dong

    Journal: EUROPEAN UROLOGY. 2026; Vol. 89, Issue 3, pp. -. DOI: 10.1016/j.eururo.2025.08.031